“…This can be mitigated by a fractionated approach and the use of hypofractionation with isotoxic dose-painting. HFRT has been explored extensively in the neoadjuvant setting, safety of 5, 37 , 38 , 39 , 40 8, 41 , 42 10, 35 , 43 , 44 and 15 fraction 45 regimens before surgery. However, few studies have explored the role of hypofractionated RT for unresectable disease.…”